Synthesis and cytotoxic activity of new acridine-thiazolidine derivatives

被引:71
作者
Barros, Francisco W. A. [2 ]
Silva, Teresinha Goncalves [1 ]
da Rocha Pitta, Marina Galdino [1 ]
Bezerra, Daniel P. [3 ]
Costa-Lotufo, Leticia V. [2 ]
de Moraes, Manoel Odorico [2 ]
Pessoa, Claudia [2 ]
de Moura, Maria Aline F. B. [4 ]
de Abreu, Fabiane C. [4 ]
Alves de Lima, Maria do Carmo [1 ]
Galdino, Suely Lins [1 ]
Pitta, Ivan da Rocha [1 ]
Goulart, Marilia O. F. [4 ]
机构
[1] Univ Fed Pernambuco, Lab Planejamento & Sintese Farmacos LPSF, Grp Pesquisa Inovacao Terapeut GPIT, BR-50670901 Recife, PE, Brazil
[2] Univ Fed Ceara, Dept Fisiol & Farmacol, Fac Med, Fortaleza, Ceara, Brazil
[3] Univ Fed Sergipe, Dept Fisiol, Ctr Ciencias Biol & Saude, Sao Cristovao, Sergipe, Brazil
[4] Univ Fed Alagoas, Inst Quim & Biotecnol, Maceio, Alagoas, Brazil
关键词
Acridine; Thiazolidines; Cytotoxicity; DNA sensors; ANTIPROLIFERATIVE ACTIVITY; ANTICANCER DRUGS; CANCER; INHIBITION; ACRIDINYLIDENE; PROLIFERATION; DESIGN; TARGET; AGENTS;
D O I
10.1016/j.bmc.2012.04.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although their exact role in controlling tumour growth and apoptosis in humans remains undefined, acridine and thiazolidine compounds have been shown to act as tumour suppressors in most cancers. Based on this finding, a series of novel hybrid 5-acridin-9-ylmethylene-3-benzyl-thiazolidine-2,4-diones were synthesised via N-alkylation and Michael reaction. The cell viability was analysed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and DNA interaction assays were performed using electrochemical techniques. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3533 / 3539
页数:7
相关论文
共 45 条
[1]   A NEW RAPID AND SIMPLE NONRADIOACTIVE ASSAY TO MONITOR AND DETERMINE THE PROLIFERATION OF LYMPHOCYTES - AN ALTERNATIVE TO [H-3] THYMIDINE INCORPORATION ASSAY [J].
AHMED, SA ;
GOGAL, RM ;
WALSH, JE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 170 (02) :211-224
[2]  
Alegaon S.G., MED CHEM RES
[3]  
Aly El-Moghazy S.M., 1994, EGYPT J PHARM SCI, V34, P401
[4]  
Antonini I, 2002, CURR MED CHEM, V9, P1701
[5]   Suppression of NF-κB and GSK-3β is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone [J].
Ban, Jung Ok ;
Kwak, Dong Hoon ;
Oh, Ju Hoon ;
Park, Eun-Jung ;
Cho, Min-Chul ;
Song, Ho Seub ;
Song, Min Jong ;
Han, Sang Bae ;
Moon, Dong Cheul ;
Kang, Keon Wook ;
Hong, Jin Tae .
CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 188 (01) :75-85
[6]   Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARγ ligands [J].
Barros, Cleiton Diniz ;
Amato, Angelica Amorim ;
de Oliveira, Tiago Bento ;
Rocha Iannini, Karime Bicas ;
da Silva, Anekecia Lauro ;
da Silva, Teresinha Goncalves ;
Leite, Elisa Soares ;
Hernandes, Marcelo Zaldini ;
Alves de Lima, Maria do Carmo ;
Galdino, Suely Lins ;
Rocha Neves, Francisco de Assis ;
Pitta, Ivan da Rocha .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (11) :3805-3811
[7]   Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells [J].
Beharry, Zanna ;
Zemskova, Marina ;
Mahajan, Sandeep ;
Zhang, Fengxue ;
Ma, Jian ;
Xia, Zuping ;
Lilly, Michael ;
Smith, Charles D. ;
Kraft, Andrew S. .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (06) :1473-1483
[8]   Acridine and acridone derivatives, anticancer properties and synthetic methods: Where are we now? [J].
Belmont, Philippe ;
Bosson, Johann ;
Godet, Thomas ;
Tiano, Martin .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (02) :139-169
[9]   Prediction of telomerase inhibitory activity for acridinic derivatives based on chemical structure [J].
Castillo-Gonzalez, Daimel ;
Angel Cabrera-Perez, Miguel ;
Perez-Gonzalez, Maykel ;
Morales Helguera, Aliuska ;
Duran-Martinez, Alexander .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (12) :4826-4840
[10]   Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones [J].
Chandrappa, S. ;
Prasad, S. B. Benaka ;
Vinaya, K. ;
Kumar, C. S. Ananda ;
Thimmegowda, N. R. ;
Rangappa, K. S. .
INVESTIGATIONAL NEW DRUGS, 2008, 26 (05) :437-444